title: Reactivation of chronic hepatitis B infection related to imatinib mesylate therapy.
abstract: Imatinib (Gleevec, Novartis), an inhibitor of BCR-ABL, platelet-derived growth factor, and KIT receptor tyrosine kinases, is widely used in the treatment of chronic myelogenous leukemia and gastrointestinal stromal tumors. We describe a case of activation of chronic hepatitis B infection associated with imatinib therapy.
authors: Section of Gastroenterology and Hepatology, Washington Hospital Center, Georgetown University School of Medicine, 110 Irving Street NW, Washington, DC, 20010, USA.
authors: Shilen
authors: S
authors: Lakhani
authors: Lev
authors: L
authors: Davidson
authors: Dennis A
authors: DA
authors: Priebat
authors: Averell H
authors: AH
authors: Sherker